BCL6 promotes the methotrexate-resistance by upregulating ZEB1 expression in children with acute B lymphocytic leukemia

被引：1

作者：

Wu, H-B ^{[1
]}

Lv, W-F ^{[2
]}

Wang, Y-X ^{[1
]}

Li, Y-Y ^{[1
]}

Guo, W. ^{[1
]}

机构：

[1] Children & Womens Healthcare Laiwu City, Childrens Hlth Sect, Laiwu, Peoples R China

[2] Laiwu City Peoples Hosp, Dept Urol Surg, Laiwu, Peoples R China

来源：

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2018年 / 22卷 / 16期

关键词：

Acute B lymphoblastic leukemia; BCL6; Methotrexate resistance; ZEB1; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL; ACTIVATION; MIGRATION; INVASION;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

OBJECTIVE: To investigate the effect of BCL6 on methotrexate-resistant children with acute B lymphoblastic leukemia (B-ALL) and its underlying mechanism. PATIENTS AND METHODS: Bone marrow samples of B-ALL children diagnosed at The Children & Women's Healthcare of Laiwu City from June 2014 to February 2017 were collected. Subjects were assigned into methotrexate-resistant group (n=8) and non-resistant group (n=32) according to the follow-up outcome. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was performed to detect expressions of BCL6 and E-cadherin in bone marrow tissues. Cell cycle and apoptosis of methotrexate-resistant B-ALL cells (BALL-1/MTXR cells) were detected after overexpression or inhibition of BCL6, respectively. Western blot was performed to determine the protein levels of E-cadherin and BCL6. The direct binding of BCL6 in the ZEB1 promoter region was verified by the ChIP (chromatin immunoprecipitation) assay. RESULTS: QRT-PCR showed a higher BCL6 expression in bone marrow samples of methotrexate-resistant group than that of the non-resistant group. Moreover, BCL6 was upregulated in BALL-1/MTXR cells than that of untreated B-ALL cells. After knockdown of BCL6 expression, we observed a decreased IC50, increased apoptosis, and arrested the cell cycle in BALL-1/MTXR cells. In addition, increased expression of E-cadherin was found in BALL-1/MTXR cells, which could be reversed by ZEB1 overexpression. ChIP assay suggested that BCL6 bound to the promoter region of ZEB1, so as to promote ZEB1 expression. CONCLUSIONS: BCL6 is overexpressed in the bone marrow of methotrexate-resistant children with B-ALL, which is capable of attenuating the sensitivity of B-ALL to methotrexate via promoting ZEB1 expression.

引用

页码：5240 / 5247

页数：8

共 23 条

[11] Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC [J].

Nahar, Rahul ;

Ramezani-Rad, Parham ;

Mossner, Maximilian ;

Duy, Cihangir ;

Cerchietti, Leandro ;

Geng, Huimin ;

Dovat, Sinisa ;

Jumaa, Hassan ;

Ye, B. Hilda ;

Melnick, Ari ;

Mueschen, Markus .

BLOOD, 2011, 118 (15) :4174-4178

[12] TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children [J].

Qian, Maoxiang ;

Cao, Xueyuan ;

Devidas, Meenakshi ;

Yang, Wenjian ;

Cheng, Cheng ;

Dai, Yunfeng ;

Carroll, Andrew ;

Heerema, Nyla A. ;

Zhang, Hui ;

Moriyama, Takaya ;

Gastier-Foster, Julie M. ;

Xu, Heng ;

Raetz, Elizabeth ;

Larsen, Eric ;

Winick, Naomi ;

Bowman, W. Paul ;

Martin, Paul L. ;

Mardis, Elaine R. ;

Fulton, Robert ;

Zambetti, Gerard ;

Borowitz, Michael ;

Wood, Brent ;

Nichols, Kim E. ;

Carroll, William L. ;

Pui, Ching-Hon ;

Mullighan, Charles G. ;

Evans, William E. ;

Hunger, Stephen P. ;

Relling, Mary V. ;

Loh, Mignon L. ;

Yang, Jun J. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) :591-+

[13] BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma [J].

Saito, Masumichi ;

Novak, Urban ;

Piovan, Erich ;

Basso, Katia ;

Sumazin, Pavel ;

Schneider, Christof ;

Crespo, Marta ;

Shen, Qiong ;

Bhagat, Govind ;

Califano, Andrea ;

Chadburn, Amy ;

Pasqualucci, Laura ;

Dalla-Favera, Riccardo .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) :11294-11299

[14] miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6 [J].

Shan, Weiwei ;

Li, Jun ;

Bai, Yang ;

Lu, Xin .

TUMOR BIOLOGY, 2016, 37 (04) :5203-5211

[15] B-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry [J].

Sundin, Andrew ;

Grzywacz, Bartosz J. ;

Yohe, Sophia ;

Linden, Michael A. ;

Courville, Elizabeth L. .

HUMAN PATHOLOGY, 2017, 61 :140-147

[16] Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1 [J].

Tijchon, Esther ;

van Emst, Liesbeth ;

Yuniati, Laurensia ;

Schenau, Dorette van Ingen ;

Gerritsen, Mylene ;

van der Meer, Laurens T. ;

Williams, Owen ;

Hoogerbrugge, Peter M. ;

Scheijen, Blanca ;

van Leeuwen, Frank N. .

EXPERIMENTAL HEMATOLOGY, 2018, 60 :57-62

[17] BCL6: A Novel Target for Therapy of Ph+ B Cell Acute Lymphoblastic Leukemia [J].

Van Etten, Richard A. .

CANCER CELL, 2011, 20 (01) :3-5

[18] Pharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina [J].

Veronica Araoz, Hilda ;

D'Aloi, Karina ;

Eugenia Foncuberta, Maria ;

Sanchez La Rosa, Christian German ;

Noemi Alonso, Cristina ;

Chertkoff, Lilien ;

Felice, Marisa .

LEUKEMIA & LYMPHOMA, 2015, 56 (05) :1370-1378

[19]

Wang YQ, 2015, AM J CANCER RES, V5, P255

[20] BCL6 promotes glioma and serves as a therapeutic target [J].

Xu, Liang ;

Chen, Ye ;

Dutra-Clarke, Marina ;

Mayakonda, Anand ;

Hazawa, Masaharu ;

Savinoff, Steve E. ;

Doan, Ngan ;

Said, Jonathan W. ;

Yong, William H. ;

Watkins, Ashley ;

Yang, Henry ;

Ding, Ling-Wen ;

Jiang, Yan-Yi ;

Tyner, Jeffrey W. ;

Ching, Jianhong ;

Kovalik, Jean-Paul ;

Madan, Vikas ;

Chan, Shing-Leng ;

Muschen, Markus ;

Breunig, Joshua J. ;

Lin, De-Chen ;

Koeffler, H. Phillip .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (15) :3981-3986

← 1 2 3 →